Anterior uveitis associated with high-dose cytosine arabinoside

Ocular Immunology and Inflammation

Volumn 18, Issue 6, 2010, Pages 485-487

  Fintelmann, Robert E ^a,b   Qian, Ying ^a,b   Skalet, Alison ^a   Jeng, Bennie H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

anterior uveitis; Ara C; cytosine arabinoside

Indexed keywords

CYTARABINE; FLUOROMETHOLONE; PREDNISOLONE ACETATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; EYE PAIN; FEMALE; HUMAN; IRIDOCYCLITIS; KERATITIS; OPHTHALMOSCOPY; PHOTOPHOBIA; SKIN REDNESS; SLIT LAMP;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; CYTARABINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; PREDNISOLONE; TREATMENT OUTCOME; UVEITIS, ANTERIOR;

EID: 78649260497     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2010.510258     Document Type: Article

References (17)

1. Dillman RO, Davis RB, Green MR, et al. A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. Blood. 1991; 78(10): 2520-2526.
2. Graves T, Hooks MA. Drug-induced toxicities associated with high-dose cytosine arabinoside infusions. Pharmacotherapy. 1989; 9(1): 23-28.
3. Fraunfelder FW, Rosenbaum JT. Drug-induced uveitis: incidence, prevention and treatment. Drug Saf. 1997; 17(3): 197-207.
4. Fraunfelder FT, Fraunfelder FW, Chambers WA. Clinical Ocular Toxicology. Philadelphia: Saunders; 2008.
5. Planer D, Cukierman T, Liebster D, Ilsar M, Chajek-Shaul T. Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside. Am J Hematol. 2004; 76(3): 304-306.
6. Moberg J, Carlsson M, Holm C, Koranyi G. Severe anterior uveitis as a complication of high-dose cytosine-arabinoside. Acta Ophthalmol. 2009; 87(8): 922-923.
7. Arbuthnot CD, Bradbury M, Darbyshire PJ. Relapsing acute myeloid leukaemia manifesting as uveitis with hypopyon. Br J Haematol. 2007; 136(4): 520.
8. Ayliffe W, Foster CS, Marcoux P, et al. Relapsing acute myeloid leukemia manifesting as hypopyon uveitis. Am J Ophthalmol. 1995; 119(3): 361-364.
9. Birnbaum AD, Tessler HH, Goldstein DA. A case of hypopyon uveitis nonresponsive to steroid therapy and a review of anterior segment masquerade syndromes in childhood. J Pediatr Ophthalmol Strabismus. 2005; 42(6): 372-377.
10. Daneshvar H, Hodge W, Gilberg S. Acute myelogenous leukaemia in an adult presenting with uveitis. Br J Ophthalmol. 1999; 83(7): 882-883.
11. Follows GA, Hutchinson C, Martin A, Carter C. Aspergillus fumigatus endophthalmitis in a patient with acute myeloid leukaemia. Clin Lab Haematol. 1999; 21(2): 143-144.
12. Greene WH, Wiernik PH. Candida endophthalmitis. Successful treatment in a patient with acute leukemia. Am J Ophthalmol. 1972; 74(6): 1100-1104.
13. Hara S, Yokote T, Oka S, et al. Endophthalmitis due to Trichosporon beigelii in acute leukemia. Int J Hematol. 2007; 85(5): 415-417.
14. Louie T, el Baba F, Shulman M, Jimenez-Lucho V. Endogenous endophthalmitis due to Fusarium: case report and review. Clin Infect Dis. 1994; 18(4): 585-588.
15. Tiribelli M, Zaja F, Fili C, et al. Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. Eur J Haematol. 2002; 68(5): 314-317.
16. Yoken J, Forbes B, Maguire AM, Prenner JL, Carpentieri D. Microsporidial endophthalmitis in a patient with acute myelogenous leukemia. Retina. 2002; 22(1): 123-125.
17. Higa GM, Gockerman JP, Hunt AL, Jones MR, Horne BJ. The use of prophylactic eye drops during high-dose cytosine arabinoside therapy. Cancer. 1991; 68(8): 1691-1693.